Rare congenital genetic disorder characterized by
papulonodular skin lesions, soft tissue masses, gingival hypertrophy, and
flexion contractures of the large joints.
Murray Syndrome; JHF; Infantile Systemic Hyalinosis;
Murray Puretic Syndrome; Puretic Syndrome.
First described by J. Murray in 1873 and reported by A.
Whitfield and A.H. Robinson in 1903.
Autosomal recessive. Gene mapped on 4q21.
May be a disorder of collagen metabolism (because
it is associated with abnormalities of collagen III and VI resulting from an
underlying defect in glycosaminoglycan formation).
Onset in infancy or early childhood. Typical
diagnostic criteria are multiple hyaline subcutaneous fibroma, filamentous
tumors of the skin, gingival fibromatosis, muscle contractures of the
extremities, and multiple osteolytic bone destruction. Features include
osteolysis, diaphyseal anomaly, thickened gingivae, subcutaneous nodules,
and restricted joint mobility. Deposits have been described in larynx,
heart, and endocrine glands.
Both direct laryngoscopy and tracheal
intubation can be difficult because of limited widening of the mouth and
laryngeal deposits. One case of unexplained resistance to succinylcholine
has been described. Preoperative cardiac function assessment can be
Murray J: On three peculiar cases of molluscum fibrosum in one family.
Med Chir Trans London 56:235, 1873.
Norman B, Soni N, Madden N: Anesthesia and juvenile hyaline fibromatosis. Br J Anaesth
Rahman N, Dunsan M, Teare ND, et al: The gene for juvenile hyaline
fibromatosis maps to chromosome 4q21. Am J Hum Genet